Insulin Resistance
Multiple type 2 diabetes benefits achievable through low-carb diets
In explaining rise of obesity, diabetes, look toward unanswered questions
Higher liver fat in children raises cardio-metabolic risk regardless of BMI
Consuming dietary fiber may reduce NAFLD risk among multiple ethnicities
Saroglitazar magnesium lowers ALT, hepatic fat in NAFLD
Sclerostin level may predict low skeletal muscle mass in adults
CMHC to offer perspectives on fighting cardiometabolic disease
Combined, diabetes, obesity and insulin resistance are the most common cause of preventable death in the United States, responsible for millions of deaths and more than $600 billion in health care costs. The Cardiometabolic Health Congress, the largest U.S.-based multidisciplinary conference centered on the management and prevention of CV and metabolic disease, is being held October 10 to 13 in Chicago for health care practitioners committed to joining the fight against cardiometabolic disease.
Screen for fatty liver as a diabetes complication
Prevalence of nonalcoholic fatty liver disease — and its more severe stage, nonalcoholic steatohepatitis, or NASH, in particular — is increasing in developed countries. The condition has surpassed alcoholism as a cause of cirrhosis and will soon be the primary cause of liver transplantation in the United States, exceeding hepatitis C, according to Kenneth Cusi, MD, FACP, FACE, chief of the division of endocrinology, diabetes and metabolism at University of Florida.